Rare diseases
Investigational molecules
Locations
Back to Italy8 clinical trials in Pontedera, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
ItalyStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
ItalyStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
ItalyItalyStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
ItalyStudy on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer
ItalyStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
ItalyStudy on Guselkumab for Healing in Crohn's Disease Patients
ItalyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on estrogen receptor-positive breast cancer treatment strategies, specifically targeting patients with high-risk node-positive disease.
Investigating innovative therapeutic approaches to improve breast cancer-free survival rates.
Comprehensive research examining the optimal timing of chemotherapy and aromatase inhibitors in post-menopausal breast cancer patients.
Analyzing treatment sequences to prevent disease recurrence in early-stage breast cancer.
Studies focused on the 80% of breast cancers that show endocrine responsiveness, investigating optimal treatment integration strategies.
Developing evidence-based approaches for combining multiple treatment modalities.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
